Tubocapsenolide A Disrupts PLK1-Linked Damage Clearance in Oxaliplatin-Resistant Colorectal Cancer
A preclinical study finds that tubocapsenolide A inhibits PLK1, disrupting ESCRT-mediated damage clearance and restoring oxaliplatin sensitivity in resistant colorectal ...
